Ownership and insider activity for Advanced Biomed Inc. Common Stock (ADVB): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product portfolio includes a suite of advanced devices: A+Pre: A fully automated system designed for pre-concentrating diluted blood samples.
Price
| Price | $7.72 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Balance Sheet (10y)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $65922 | $4.8M | $2.6M | $2.6M | $2.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | $419 | $162518 | $4814 | $6324 | $7956 |
| Inventory | 0 | 0 | 0 | -$6324 | 0 |
| Total Current Assets | $913497 | $5.0M | $2.8M | $3.1M | $6.0M |
| Property, Plant & Equipment | $92876 | $1.2M | $954070 | $651269 | $65.4M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | $410799 | $250321 | $118998 | 0 |
| Total Assets | $1.0M | $6.7M | $4.6M | $4.5M | $6.5M |
| Accounts Payable | $194 | $762202 | $632820 | $620476 | $21658 |
| Short-term Debt | $188 | $7959 | $6953 | $1917 | $1.1M |
| Total Current Liabilities | $28350 | $3.0M | $3.3M | $2.7M | $2.9M |
| Long-term Debt | 0 | 0 | 0 | 0 | $139772 |
| Total Liabilities | $30131 | $3.2M | $3.3M | $2.8M | $3.0M |
| Retained Earnings | -$5.4M | -$9.5M | -$13.2M | -$16.0M | -$19.2M |
| Total Equity | $976242 | $3.5M | $1.3M | $1.7M | $3.5M |
| Total Debt | $7209 | $476827 | $242326 | $128657 | $1.3M |
| Net Debt | -$58713 | -$4.3M | -$2.4M | -$2.5M | -$1.6M |
| Working Capital | $885147 | $2.0M | -$489595 | $318650 | $3.1M |
Financial Health
| Debt / Equity | 0.08 |
| Current Ratio | 7.38 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -0.61 |
Profitability
| Return on Equity | -20.71% |
| Return on Invested Capital | -11.04% |
| Return on Assets | -6.36% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: APM · BGLC · CHEK · GELS · MBIO · MRKR · RDGT
Explore sector: Healthcare · Medical - Diagnostics & Research
More sections of ADVB: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks